Drug · DIN 02444852
BASAGLAR
KWIKPEN - 60 UNITS PER INJECTION DELIVERY
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 22, 2019; first marketed December 18, 2015.
- Drug Identification Number (DIN)
- 02444852
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin glargine A10AE04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN GLARGINE | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2015: NOC 17245New Drug Submission (NDS)
Other DINs named BASAGLAR
- DIN 02444844 · Marketed
- DIN 02461528 · Marketed